Overview
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Lobbying Costs
None declared
Financial year: Jan 2020 - Dec 2020
Lobbyists (Full time equivalent)
3 Fte (12)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
European Federation of National Associations of Orthopaedics and Traumatology (EFORT)
EU Transparency Register
241995833892-89 First registered on 27 Feb 2019
Goals / Remit
EFORT, the European Federation of National Associations of Orthopaedics and Traumatology, is the platform
organisation linking Europe‘s national orthopaedic associations. Its aims to reflect the will to promote the exchange of scientific knowledge and experience in the field of prevention and both the conservative and surgical treatment of diseases and injuries concerning the musculoskeletal system. Its mission is to work on behalf of the European Orthopaedic and Traumatology Community to restore and secure mobility, musculoskeletal health and through this, quality of life.
Its strategy focusses on four pillars that support these aims: education, harmonisation of guidelines &
standards, influencing European health policy, and finally research.
The national associations of orthopaedics and traumatology from twenty European countries established EFORT by consensus. The Federation was founded in Marentino, Italy, in 1991Main EU files targeted
EFORT’s various initiatives ambition to elevate the burden of musculoskeletal conditions in Europe to a recognized condition on the European agenda and to include it in research and public health activities, so to guide future EU strategies. There are today clear cross border inequalities and standards of care for treatment are still too disparate.
Additionnally, EFORT is involved in issues pertaining to medical devices, especially within the CORE MD project.Address
Head Office
ZA La Piece 2
Rolle 1180
SWITZERLANDEU Office
ZA La Piece 2
Rolle 1180
SWITZERLANDWebsite
-
People
Total lobbyists declared
12
Employment time Lobbyists 25% 12 Lobbyists (Full time equivalent)
3
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Non-governmental organisations, platforms and networks and similar
-
Networking
Affiliation
EFORT is member of:
Biomed Alliance www.biomedeurope.org
AC Forum: www.acforum.net
Health First Europe www.healthfirsteurope.euMember organisations
None declared
-
Financial Data
Interests represented
Does not represent commercial interests
Closed financial year
Jan 2020 - Dec 2020
Lobbying costs for closed financial year
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Total organisational budget in closed year
755,400€
Major funding types in closed year
Other, Member's contribution, Grants
Funding types "other" information
Major contributions in closed year
Type Name Amount Contribution Grünenthal 80,000€ Contribution Stryker 121,500€ Other financial info
None declared
-
EU Structures
Groups (European Commission)
Medical Device Coordination Group#X03565#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?groupID=3565 #Observer #C#Professionals#03 - Clinical Investigation and Evaluation (CIE)
Groups (European Parliament)
Artificial intelligence and digital#-Observers in the new subgroups of the Medical Device Coordination Group (MDCG) and now also invited to participate in the meeting between MDCG and stakeholders
-Invitation for EFORT to speak at the EU parliament (4 April) on "The importance of registers to determine the quality of implants and to stop usage of failing devices"
-SCENIHR
--Expert panels: EFORT chairs the Thematic panel for Orthopaedics, Traumatology, Rehabilitation,
Rheumatology and has a representative in the Screening PanelCommunication activities
Trying to match EFORT’s initiatives notably based on the "10 political priorities of the Juncker Commission" in order to influence the European Health agenda in the field of musculoskeletal health would probably focus on the following aspects:
- Job, Growth and investment
- A deeper and fairer internal market with a strengthened industrial base
- A balanced and progressive trade policy to harness globalisation
EFORT has been active within the European Reference Network with a specific objective to make Health care systems effective, accessible and resilient (1.4 of the Management Plan 2018 for DG Health and Food Safety – SANTE). Similarly for increased access to medical expertise and information for specific conditions (1.5 of the Management Plan 2018 for DG Health and Food Safety – SANTE)
As another activity NORE is an all-inclusive network that fosters international collaboration and co-ordination of learning and research in orthopaedics, with special focus on medical device surveillance, arthroplasty outcome, and other registries of orthopaedic conditions in order to support improvements in patient care. The specific objective 1.6: Effective, efficient and reliable official controls (Management Plan 2018 for DG Health and Food Safety – SANTE) proposes “to carry out approximately 40 joint assessments of notified bodies designated under the medical devices and in vitro diagnostic medical devices Regulations”. This ties into registry activities and is likely to firm EFORT’s position expressed in recently published statements:
-New Medical Devices Regulations (MDR) and In Vitro Diagnostic Medical Devices Regulations (IVDR) - https://www.efort.org/mdr/
-Are Orthopaedic and Trauma implants safe? - https://www.efort.org/efort-are-orthopaedic-and-trauma-implants-safe/
Another good example is the specific objective 2.1: Effective EU assessment of medicinal products and other treatment (Management Plan 2018 for DG Health and Food Safety – SANTE). Through the EFORT affiliation to Biomed Alliance demonstrates our belief that a collaborative framework for the clinical assessment of health technologies is necessary to support high-quality healthcare in Europe.
-European Doctors unite to demand policymakers support for EU-Level HTA - https://www.efort.org/jt-hta/
Further EFORT was represented in the recently held JRC Ispra meeting on medical devices of 11 February aiming at the finalisation of the landscape of the expert panels and the finalisation of the list of medical specialties and subspecialties that should be used for the call for experts.
EFORT has also been confirmed as observer in the subgroup Clinical Investigation and Evaluation (CIE) of the Medical Devices Coordination Group (MDCG).
Earlier and through input and participation in SCENIHR Metal on Metal controversies were discussed.
-European Commission issued Final Opinion on the Safety of Metal-on-Metal (MoM) Joint Replacements with a particular focus on hip implants – https://www.efort.org/eu_commission_mom/Other activities
None declared
Meetings
Meetings
None declared